How should I manage a patient with insomnia who is taking melatonin 6 mg, bupropion 150 mg, and escitalopram (Lexapro) 5 mg?

Discontinue Melatonin and Address Medication-Induced Insomnia

Stop the melatonin immediately—it is not effective for insomnia and may be contributing to the problem—and recognize that bupropion 150 mg is likely the primary culprit causing or worsening this patient's insomnia. 1

Primary Issue: Bupropion-Induced Insomnia

The American Academy of Sleep Medicine guidelines explicitly recommend against using melatonin for treatment of sleep onset or sleep maintenance insomnia in adults 1. The FDA labeling for bupropion clearly lists insomnia as a common adverse effect and specifically warns clinicians to monitor for "anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness" during treatment 2. This patient's insomnia is most likely medication-induced.

Immediate Management Steps:

1. Discontinue melatonin 6 mg - It lacks efficacy and the guidelines recommend against its use 1

2. Address the bupropion timing:

• Move bupropion administration to early morning (immediately upon waking)
• If already taking in morning, consider dose reduction to 75 mg or discontinuation if clinically appropriate for the underlying depression
• The low dose of Lexapro (5 mg) suggests the depression may not be severe, making bupropion adjustment more feasible

3. Evaluate if Lexapro alone at optimized dosing (10-20 mg) could manage the depression without bupropion, eliminating the activating agent

Evidence-Based Pharmacologic Options for Insomnia

If insomnia persists after addressing medication causes, the AASM guidelines provide clear recommendations 1:

For Sleep Onset Insomnia:

• Ramelteon 8 mg (melatonin receptor agonist) - WEAK recommendation
• Zaleplon 10 mg - WEAK recommendation
• Zolpidem 10 mg - WEAK recommendation

For Sleep Maintenance Insomnia:

• Doxepin 3-6 mg - WEAK recommendation (particularly useful here as it won't worsen depression)
• Suvorexant (orexin receptor antagonist) - WEAK recommendation
• Eszopiclone 2-3 mg - WEAK recommendation

Specific Consideration for This Patient:

Doxepin 3-6 mg at bedtime is the most appropriate choice if pharmacotherapy is needed after addressing the bupropion issue 1. It treats sleep maintenance insomnia, has antidepressant properties at higher doses (won't interfere with depression treatment), and can be safely combined with escitalopram. One study demonstrated that zolpidem extended-release combined with escitalopram improved insomnia symptoms without compromising antidepressant efficacy 3, though this was with higher escitalopram doses.

Critical Pitfalls to Avoid:

• Do not add another medication before removing the offending agent (bupropion causing insomnia)
• Do not continue ineffective melatonin - guidelines are clear it doesn't work 1
• Avoid trazodone - despite common off-label use, AASM guidelines recommend against it 1
• Avoid antihistamines (diphenhydramine) - explicitly not recommended 1
• Monitor for serotonin syndrome if adding any sleep medication to the SSRI, though risk is low with recommended agents 4

Lexapro Considerations:

The FDA labeling notes that "trouble sleeping" is a common side effect of Lexapro 4, though at 5 mg this is less likely. However, the combination of bupropion (activating) with escitalopram may be synergistically worsening insomnia.

Algorithm for This Patient:

1. Stop melatonin immediately
2. Move bupropion to early morning OR reduce dose OR discontinue
3. Wait 1-2 weeks to assess if insomnia improves with medication adjustment alone
4. If insomnia persists: Add doxepin 3-6 mg at bedtime OR ramelteon 8 mg
5. Consider increasing Lexapro to 10 mg if depression symptoms warrant and bupropion is discontinued
6. Reassess in 2-4 weeks - if no improvement, switch to zolpidem 10 mg or eszopiclone 2-3 mg for short-term use

The evidence strongly supports that this patient's insomnia is iatrogenic, and the solution begins with medication rationalization rather than adding more drugs.